Pramana
Private Company
Funding information not available
Overview
Pramana, founded in 2020 and based in San Francisco, is innovating in the digital pathology space with its Spectral family of autonomous, modular whole slide scanners. Its core value proposition addresses critical pain points in labs: manual operations, underutilized scanner capacity, and the limitations of cloud-based image analysis through built-in quality assurance and real-time edge AI processing. The company's technology, which includes patented volumetric imaging, is designed for research use and partners with leading healthcare organizations to modernize pathology workflows. In a significant development, Pramana's digital pathology business has been acquired by Evident, the scientific solutions division of Olympus.
Technology Platform
Autonomous, modular whole slide imaging systems with integrated edge AI and patented volumetric imaging for real-time analysis and high-throughput digital pathology.
Opportunities
Risk Factors
Competitive Landscape
Pramana competes in the digital pathology scanner market against large, established players like Roche (Ventana), Philips, and Leica Biosystems, as well as other startups. Its key differentiators are its modular scalability, fully autonomous operation with inline QA, and unique edge AI capability enabling real-time analysis during scanning, a feature not commonly offered by first-generation systems.